EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parolari, A.
Right arrow Articles by Biglioli, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parolari, A.
Right arrow Articles by Biglioli, P.

European Journal of Cardio-Thoracic Surgery, Vol 9, 77-82, Copyright © 1995 by European Association for Cardio-thoracic Surgery


ARTICLES

The effect of "high dose" aprotinin and other factors on bleeding and revisions for bleeding in adult coronary and valve operations: an analysis of 2190 patients during a five-year period (1987-1991)

A Parolari, C Antona, P Gerometta, F Alamanni, R Spirito, V Arena, A Sala and P Biglioli
Department of Cardiac Surgery, University of Milan, Italy.

We retrospectively evaluated risk factors for postoperative bleeding and for revisions due to bleeding in 2190 adult coronary and valve patients who underwent surgery at our hospital during the 5-year period from 1987 to 1991. During this period 889 (40.6%) patients were given "high dose" aprotinin. Their mean age was 59.3 +/- 8.8 years, 1636 (74.7%) were males, 200 (9.1%) underwent surgery on an emergency basis and 72 patients (3.3%) underwent redo-operations. The patients were divided into four groups according to the type of surgery: all patients pooled together (2190), coronary artery surgery patients (1384, 63.2%, group I), valve surgery patients (706, 32.2%, group II) and combined (coronary plus valve) surgery patients (100, 4.6%, group III). Stepwise logistic regression analysis, performed to assess the risk factors for revisions due to bleeding showed aprotinin treatment to be the sole protective factor in all patients, group I and group II. In group III only the use of a hollow fiber membrane oxygenator proved a protective factor. Risk factors for revisions for bleeding were found to be aortic cross-clamp time in all patients, group I and group II. Use of the internal thoracic artery (ITA) was significant in group I patients and age at operation in group II. Multiple stepwise linear regression analysis, performed to evaluate the effect of various risk factors on cumulative postoperative blood loss in all patients, confirmed aprotinin as the only factor capable of reducing blood loss, while aortic cross-clamp time, coronary surgery and male gender showed a positive linear relation with postoperative bleeding.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
The Society of Thoracic Surgeons Blood Conservatio, V. A. Ferraris, S. P. Ferraris, S. P. Saha, E. A. Hessel II, C. K. Haan, B. D. Royston, C. R. Bridges, R. S.D. Higgins, G. Despotis, et al.
Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline
Ann. Thorac. Surg., May 1, 2007; 83(5_Supplement): S27 - S86.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
D. M. Arnold, D. A. Fergusson, A. K.C. Chan, R. J. Cook, G. A. Fraser, W. Lim, M. A. Blajchman, and D. J. Cook
Avoiding transfusions in children undergoing cardiac surgery: a meta-analysis of randomized trials of aprotinin.
Anesth. Analg., March 1, 2006; 102(3): 731 - 737.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. M. Moskowitz, J. J. Klein, A. Shander, K. M. Cousineau, R. S. Goldweit, C. Bodian, S. I. Perelman, H. Kang, D. A. Fink, H. C. Rothman, et al.
Predictors of transfusion requirements for cardiac surgical procedures at a blood conservation center
Ann. Thorac. Surg., February 1, 2004; 77(2): 626 - 634.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
A. Parolari, D. Guarnieri, F. Alamanni, T. Toscano, V. Tantalo, T. Gherli, S. Colli, F. Foieni, V. Franze, M. Stanghellini, et al.
Platelet Function and Anesthetics in Cardiac Surgery: An In Vitro and Ex Vivo Study
Anesth. Analg., July 1, 1999; 89(1): 26 - 26.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. M. Al Khudhairi, F. Nadeem, A. M. M. Zuleika, A. Hussain, A. Ahmed, and M. E. Sharkawy
Effect of Aprotinin on Plasma Fibronectin Levels During Cardiopulmonary Bypass
Ann. Thorac. Surg., January 1, 1997; 63(1): 64 - 67.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
J. T. Christenson, J. Reuse, P. Badel, F. Simonet, and M. Schmuziger
Plateletpheresis Before Redo CABG Diminishes Excessive Blood Transfusion
Ann. Thorac. Surg., November 1, 1996; 62(5): 1373 - 1378.
[Abstract] [Full Text]


Home page
PerfusionHome page
Bo Liu, A. Belboul, S. Larsson, and D. Roberts
Factors influencing haemostasis and blood transfusion in cardiac surgery
Perfusion, March 1, 1996; 11(2): 131 - 143.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1995 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.